Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)

SHA:600211 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,921	1,648	1,860	1,140	764.41	768.52
Trading Asset Securities	1,205	976.62	515.34	792.49	537.87	14.96
Cash & Short-Term Investments	3,126	2,625	2,375	1,932	1,302	783.48
Cash Growth	1.57%	10.51%	22.92%	48.38%	66.22%	-5.64%
Accounts Receivable	718.36	732.82	856.71	625.68	632.32	476.66
Other Receivables	12.44	11.85	11.82	12.63	12.83	12.1
Receivables	730.8	744.67	868.52	638.31	645.15	488.76
Inventory	148.8	134.19	111.43	99.95	137.32	70.85
Prepaid Expenses	-	0.31	0.01	1.5	-	-
Other Current Assets	59.17	65.91	47.77	40.04	97.16	8.02
Total Current Assets	4,065	3,570	3,403	2,712	2,182	1,351
Property, Plant & Equipment	661.6	669.85	600.33	551.38	764.54	204.46
Long-Term Investments	119.64	120.38	103.85	129.75	130.25	139.07
Goodwill	8.88	8.88	8.88	8.88	8.88	8.88
Other Intangible Assets	177.66	184.09	202.46	416.48	411.66	943.46
Long-Term Deferred Tax Assets	145.26	151.05	115.48	71.34	67.16	23.44
Long-Term Deferred Charges	2.51	2.63	1.93	2.79	47.69	21.53
Other Long-Term Assets	41.53	40.55	151.57	206.96	190.57	252.35
Total Assets	5,222	4,747	4,587	4,100	3,803	2,944
Accounts Payable	15.84	13.5	5.51	14.37	13.22	7.19
Accrued Expenses	70.47	377.65	530.39	412.7	398.67	271.15
Short-Term Debt	516.18	272.17	499.99	486.1	534.66	-
Current Portion of Leases	-	0.92	0.88	1	2.13	-
Current Income Taxes Payable	-	25.5	45.31	27.13	22.13	11.45
Current Unearned Revenue	5.45	4.91	9.84	5.34	3.29	3.64
Other Current Liabilities	444.9	71.92	92.56	79.56	135.56	39.65
Total Current Liabilities	1,053	766.57	1,184	1,026	1,110	333.08
Long-Term Debt	-	-	-	-	-	10.42
Long-Term Leases	0.13	0.3	1.13	1.14	1.86	-
Long-Term Unearned Revenue	27.05	27.36	25.85	27.53	30.5	10.76
Long-Term Deferred Tax Liabilities	5.89	1	2.29	14.01	15.61	1.65
Total Liabilities	1,086	795.23	1,214	1,069	1,158	355.91
Common Stock	322.32	322.32	247.94	247.94	247.94	247.94
Additional Paid-In Capital	1,188	1,188	1,263	1,266	1,265	1,264
Retained Earnings	2,514	2,330	1,773	1,455	1,169	1,086
Comprehensive Income & Other	75.95	77.57	61.21	42.98	-51.42	-22.41
Total Common Equity	4,101	3,918	3,345	3,012	2,630	2,576
Minority Interest	35.26	34.29	29.03	19.03	14.66	12.3
Shareholders' Equity	4,136	3,952	3,374	3,031	2,645	2,588
Total Liabilities & Equity	5,222	4,747	4,587	4,100	3,803	2,944
Total Debt	516.31	273.39	501.99	488.25	538.65	10.42
Net Cash (Debt)	2,610	2,351	1,873	1,444	763.63	773.07
Net Cash Growth	12.83%	25.54%	29.71%	89.11%	-1.22%	-6.90%
Net Cash Per Share	8.11	7.29	5.80	4.48	2.36	2.40
Filing Date Shares Outstanding	320.57	322.32	322.32	322.32	322.32	322.32
Total Common Shares Outstanding	320.57	322.32	322.32	322.32	322.32	322.32
Working Capital	3,012	2,803	2,218	1,686	1,072	1,018
Book Value Per Share	12.79	12.16	10.38	9.34	8.16	7.99
Tangible Book Value	3,914	3,725	3,133	2,586	2,210	1,624
Tangible Book Value Per Share	12.21	11.56	9.72	8.02	6.86	5.04
Buildings	-	580.07	462.4	389.99	439.89	150.59
Machinery	-	447.84	446.34	139.22	159.08	112.38
Construction In Progress	-	65.06	60.71	153.6	272.13	55.45

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.